MOVING TOWARD A TRULY INDIVIDUALIZED PREDICTIVE MODEL

For patients, fertility treatment is complex. Celmatix aims to make the path clearer by pioneering the methods and technologies that will help doctors design personalized treatment plans to guide patients to their highest probability of a successful outcome. We do this by focusing our research on two key areas: genetic biomarker discovery and advanced clinical analytics. By designing tools and technologies that incorporate genomic research with data science, our offerings help physicians interpret data, clarify the causes of treatment failure, and optimize treatment strategies to improve success rates.

  • 1/3

Today clinicians consider a range of options before beginning treatment. With early access to better data analytic and genetics-based prognostic tools, physicians can more easily identify optimal treatment strategies.


“68% of IVF treatment cycles in women under 40 do not result in a live birth.”

— SART 2009

PIONEERING RESEARCH AT THE INTERSECTION OF GENOMICS AND DATA SCIENCE

Celmatix aims to identify the underlying genetic causes of infertility while advancing clinical analytical for predicting reproductive outcomes.

Decoding the human genome provides great promise for identifying the underlying causes of infertility

Even after extensive testing is complete, over 20% of couples will have no explanation for their fertility difficulties. Using whole genome sequencing and CGH arrays, our team of data and bioinformatic scientists have identified Fertilome™, the regions of the human genome that are most likely to encode a woman’s fertility potential. This research is paving the way for the first generation of genetic biomarkers that will help to clarify otherwise unexplained infertility and predict premature decline in ovarian reserve and function.

Understanding the entire treatment journey is the key to maximizing success

Treatment decisions can be complex, yet most predictive models have focused to date on a few simple clinical metrics to predict success for a single treatment cycle at a time. Celmatix data scientists are changing this by creating the world’s first multi-variant models that compute the cumulative probability of success across the entire treatment journey on a personalized basis, for a particular couple. Powered by a fast-growing clinical database that already includes more than 100,000 treatment cycles, Celmatix is helping power evidence-based decision making.


DIAGNOSTIC: A STREAMLINED USE CASE

    • 1

    As part of initial diagnostic work-up for infertile couple, physician collects blood for Celmatix genetic testing. Physician and patient also provide Celmatix with additional phenotypic data (e.g. age, peak hormone levels, environmental exposure history).

    • 2

    Celmatix utilizes information to identify high risk of aneuploidy and recurrent miscarriage based on genetic and phenotypic indicators.

    • 3

    Physician counsels patient that moving directly to IVF with PGS is highest probability route to healthy pregnancy. Patient becomes pregnant in first cycle. By reducing patient’s emotional stress, physician increases likelihood of referrals, higher volumes and retentions.


ANALYTICS: A CLINIC WITH ACTIONABLE INFORMATION

    • 1

    Clinic uploads or links patient data from electronic medical record to Celmatix for analysis.

    • 2

    Celmatix predictive algorithms and analytics reveal non-obvious correlations useful for improving best practices on a clinic-wide level and personalized outcome predictions with different treatment strategies for patients.

    • 3

    With greater certainty of what is driving treatment success, patients achieve viable pregnancies more rapidly and clinics benefit from improved overall success rates.


“Everyone’s tracking data. Celmatix is taking it to the next level.”

— Dr. Alan Copperman, MD. Director, Reproductive Medicine Associates of New York

HOW CELMATIX HELPS OPTIMIZE TREATMENT DECISIONS

Currently, fertility specialists and patients navigate treatment options with personalized clinical data such as hormone levels and age, but without the power of analytics to understand complex and higher order relationships within this data.

This can be complex, frustrating, and involve multiple failed cycles. Celmatix offerings streamline the process, making treatment decisions clearer, more efficient and less stressful.


 

  • 1/3

Numerous treatment options with existing data


POWERFUL TOOL FOR OPTIMIZING TREATMENT DECISIONS

Introducing Polaris™, a clinical decision support platform that incorporates Celmatix’s powerful predictive clinical models and helps physicians and clinics explain the effectiveness and cost feasibility of fertility treatments across the entire journey.


 

  • 1/2


careers

Celmatix is a rapidly expanding, New York City-based biotechnology company targeting the reproductive medicine sector. Our ultimate mission is to help women maximize their fertility, now and in the future. We are looking for talented and accomplished individuals to join our growing team. Our offices are in the meatpacking district, right in the heart of a thriving arts and cultural scene. We offer a full range of benefits including:
- Competitive salary and compensation
- Full medical insurance
- 401K
- Pre-tax FSA and transit benefits


Our current openings are listed below. If you don’t see the exact role you are looking for, introduce yourself on the contact page. We would love to meet you.
- Front End Web Developer (New York, NY)
- Ruby on Rails Developer (New York, NY)
- Product Manager (New York, NY)
- Data Scientist (New York, NY)


WHERE YOU COME IN

We’re looking for collaborators.

We have identified a number of promising biomarkers in our pilot studies, and are seeking clinical centers of excellence around the world in which to test the prevalence and utility of these markers in different geographical populations.

By expanding our patient pool, we hope to uncover additional biomarkers that could be useful for screening particular populations across the globe.

Your Name (required)

Your Email (required)

Your Message


captcha

Contact



 

Contact Form







captcha

News

May 14, 2014

Celmatix Begins Clinical Trials For Big Data-Based Fertility Planning Services

TechCrunch announces the launch of the clinical trial for Polaris, the world’s first informatics platform for maximizing fertility.

April 2, 2014

Celmatix Founder and CEO named to Inc.com’s Women to Watch in Tech in 2014

Celmatix Founder and CEO Dr. Piraye Yurttas Beim was named one of Inc.com’s top Women to Watch in Tech in 2014. Dr. Beim joins a distinguished class of ten global female entrepreneurs who are making “impressive–and in some cases, world-changing–innovations.”

October 17, 2013

Celmatix Study Shows Women May Be Stopping IVF Treatment Prematurely

Presentations at ASRM demonstrate progress toward developing a truly personalized predictor for reproductive outcomes – Celmatix, a biotechnology company focused on helping physicians guide patients to treatments that maximize their personal reproductive potential, announced today six research presentations at the annual meeting of the American Society for Reproductive Medicine (ASRM), being held October 12-17 in Boston. Among the data presented was a new study suggesting that up to 25 percent of patients may be discontinuing assisted reproductive therapies such as in vitro fertilization (IVF) early, while they still have a good chance of having a baby. The clinical study, which was performed on a dataset of over 6,000 patients from study co-authors Reproductive Medicine Associates of New York, showed that 68 percent of women conceived within two cycles. For those who did not conceive in that time frame and chose to discontinue treatment, the data suggested that more than half (60 percent) would have become pregnant if they had proceeded with an additional two treatment cycles. Other Celmatix findings being presented at ASRM include data on genetic markers related to currently unexplained female infertility and IVF success; factors correlated with higher risk of ectopic pregnancy; and an analytical model that predicts the estimated number of cycles needed by a particular couple to achieve live birth using various fertility treatments. READ MORE

March 25, 2013

Celmatix Founder and CEO Named to Crain’s New York’s Forty Under Forty list for 2013

Celmatix’s Founder and CEO Dr. Piraye Yurttas Beim has been named to Crain’s New York’s Forty Under Forty list. This annual list includes top New York business leaders including Neil Blumenthal, Co-founder and Co-CEO of Warby Parker, and Ben Smith, Founder and CEO of Buzzfeed.

December 15, 2012

Celmatix Founder Reports from Front Lines of Personalized Reproductive Medicine Revolution at Futures of Reproduction Conference in Cambridge, UK

Dr. Piraye Yurttas Beim, Paints Optimistic Future for Women Struggling with Infertility. Cambridge, UK (December 15, 2012) —
Piraye Yurttas Beim, PhD, Founder and CEO of the biotech firm Celmatix Inc., and a leading international expert in the genetics of female infertility, presented A Report from the Front Lines of the Personalized Reproductive Medicine Revolution at the Futures in Reproduction Conference at the Churchill College, Cambridge, a two-day meeting celebrating the spirit of inquiry personified by Nobel Prize winner Professor Sir Robert Edwards.

In the not so distant future, Dr. Beim predicts things will be very different for women who struggle with infertility. The pairing of “big data” analytics with genomics is helping Celmatix decipher the genetic drivers of infertility and usher in an era of personalized reproductive medicine by determining which treatments work best for individuals and developing targeted therapies and treatment plans, something that is being done in cancer treatment already. READ MORE

March 19, 2012

Celmatix Advisory Board Member Dr. Roger Gosden Honored in Special Issue of Molecular Human Reproduction

Professor Stephen J Hillier writes, “As a practitioner of ‘translational’ research, Roger Gosden’s contributions have been immense. Over a career spanning four decades, he has published numerous influential articles in peer-reviewed journals and books dealing with the fertility and fecundity of various mammalian species from mouse to (wo)man.” READ MORE

March 8, 2012

Celmatix Receives Additional Financing

New York City-based Celmatix Inc. announced today it has secured $1.5 million in additional financing. These funds were raised after encouraging early results from the Company’s genomic and data analytic research pipelines. READ MORE

February 27, 2011

Celmatix Completes Series A Financing

Celmatix Inc., an emerging biotechnology company focused on reproductive medicine, announced today the closing of a Series A financing round led by Topspin Partners. This follows initial funding through seed investment and government grants. READ MORE

Media Contact

John Carter
EVC Group
jcarter@evcgroup.com
617.283.3969

Celmatix Publications

  • Fertility & Sterility
    American Society for Reproductive Medicine
    August 2011
    (PDF Download)
  • Fertility & Sterility, Vol. 97, No. 3, Part 1
    Pacific Coast Reproductive Society Meeting
    March 2012
    (PDF Download)
  • Fertility & Sterility, Vol. 97, No. 3, Part 2
    Pacific Coast Reproductive Society Meeting
    March 2012
    (PDF Download)
  • Fertility & Sterility
    American Society for Reproductive Medicine
    October 2012
    (PDF Download)

  • Laura Towart Bandak, MSc
  • Laura Towart Bandak, MSc

    Founder and Chairman

    linkedin

Laura Towart Bandak holds an MSc degree in Neuroscience from Cornell University (Weill Medical College/Sloan Kettering Institute, NYC). She performed her thesis work on the molecular pharmacology of the mu opioid receptor and is published in the field of gonadal hormones. In addition, Ms. Bandak has had extensive exposure to the biotechnology sector as an independent consultant. Ms. Bandak graduated cum laude from The George Washington University, Washington DC, with a BA in English Honors and a BS in Biology.


  • Piraye Yurttas Beim, PhD
  • Piraye Yurttas Beim, PhD

    Founder and Chief Executive Officer

    linkedin

Regarded as an expert in female infertility, Dr. Beim’s embryology research at Cambridge (UK) and doctoral work at Cornell (Weill) on the molecular genetics of mammalian infertility took a very personal turn when she began to notice many of the successful and career-minded women in her network begin to voice strong concerns about their biological clocks. That is when it dawned on her: What if women could understand their own fertility based on data and biology rather than age alone? How would that change how women made life-defining decisions? In that moment, Celmatix was born. Dr. Beim has also been widely recognized as an emerging business leader. She was most recently named a NYC Venture Fellow by the NYCEDC and to Crain’s 40 Under 40. She lives in New York City with her husband and son.

  • Michael Elashoff, PhD
  • Michael Elashoff, PhD

    Vice President of Research & Development

    linkedin

Prior to his work at Celmatix, Mike was the Senior Director of Biostatistics at CardioDx, where he developed the Corus CAD test, the first blood based molecular diagnostic for coronary disease. Previously, he was director of biostatistics at Gene Logic, which at that time had the largest genomic database in the world, and was a reviewer and team leader at the FDA’s Center for Drug Evaluation and Research. He received an undergraduate degree in Statistics from the University of California at Berkeley and a PhD in Biostatistics from the Harvard University School of Health. Besides research/science, he plays pool and soccer.


  • Angie Lee
  • Angie Lee

    Vice President of Product & Marketing

    linkedin

Prior to joining Celmatix, Angie held senior leadership roles overseeing marketing and product at General Assembly, IDEO, HarperCollins Publishers and News Corporation. She earned her BA from the Business Honors Program at The University of Texas at Austin and an MBA with concentrations in Strategy and Marketing from New York University’s Stern School of Business. On the weekends, you can find her picnicking in Prospect Park, Brooklyn with her husband and two kids.


  • James Leslie
  • James Leslie

    Chief Financial Officer

    linkedin

Prior to his work at Celmatix, he was CFO of TitleVest, a tech-enabled company operating in the real estate space where he oversaw all financial functions while also providing strategic and operational direction during a period where the company tripled in size and expanded across the US. Formerly, James was as an investment banker with The Blackstone Group, a global investment and advisory firm, where he advised institutional clients on numerous multi-billion dollar transactions, offering guidance on financial planning and budgeting, cash flow forecasting, strategic and operational planning and capital structure considerations. He earned an undergraduate degree from from Vassar College and an MBA from Columbia Business School. In his spare time, James races J/24 sailboats and runs the occasional 10k.


Mr. Winick is a partner of Topspin Partners, a lead investor in Celmatix. He came to Topspin from Honeywell, Intl., where he most recently served as CIO of its $2 billion Security Group. Mr. Winick received a BS in economics from the Wharton School of the University of Pennsylvania and a BS in electrical engineering, also from the University of Pennsylvania.


  • Benjamin Burnett
  • Benjamin Burnett

    Bioinformatics Associate

    linkedin

Prior to joining the Celmatix team, Ben was a research associate at the Itsik Pe’er Lab of Computational Genetics, where he developed pipelines to analyze epistatic interactions in diseased individuals across the human genome. In addition, he spearheaded the development of novel fixatives and delivery methods for the fragrance company Nomaterra. Ben graduated with honors from Columbia University with a BS in Biochemistry and Mathematics. In his spare time, he loves travel and playing music.


  • Rebecca Chodroff, PhD
  • Rebecca Chodroff, PhD

    Product Manager

    linkedin

Prior to her work at Celmatix, Rebecca was a recipient of an NIH-Oxford Biomedical Research Scholarship which allowed her to split her graduate studies between Oxford University and the National Human Genome Research Institute. She received her undergraduate degree in Neuroscience and Anthropology from the University of Pennsylvania where she graduated summa cum laude, and a PhD in Genetics from Oxford University where her thesis focused on elucidating the roles of non-protein-coding RNAs in mammalian brain development. When not at work, she can be found jogging through Prospect Park, drinking very strong coffee, or looking for new places to sail.


Prior to his work at Celmatix, Nick was a web developer at the Strategic Resource Group in New York, where he designed and developed web products for retail and consumer packaged goods companies. He received his undergraduate degree in Ecology and Evolutionary Biology from Princeton University in 2011, where he used geospatial analysis to assess the potential impact of climate change on the stream ecosystems of Montana. In his spare time he likes to long bicycle rides on the beach and starting new hobbies.


  • Charlotte Frank Sage, PhD
  • Charlotte Frank Sage, PhD

    Manager of Clinical Affairs

    linkedin

Prior to her work at Celmatix, Charlotte was the Vice President of Clinical Affairs and Operations at Extend Fertility, a pioneering company in the field of female fertility preservation. She received her undergraduate degree in Molecular Biology and Biochemistry from Wesleyan University where she graduated first in her class. She holds a PhD in Microbiology from Yale University, where she studied the interactions of the yeast Candida albicans with human intestinal epithelial cells. She also enjoys teaching the next generation of scientists as part of the Overnight Program at the Museum of Science, Boston.


  • Sam Globus, PhD
  • Sam Globus, PhD

    Manager of Scientific Operations

    linkedin

Prior to his work at Celmatix, Sam was an Associate Consultant at Bionest Partners. Sam received his undergraduate degree from Wesleyan University, an MA in Biotechnology from Columbia, and an MSc in the History of Science and Technology from Oxford. He completed a PhD in Molecular Biology and Biochemisty from Weill Cornell University Medical College where his research, performed at the Memorial Sloan-Kettering Cancer Center, focused on the basic molecular processes that can lead to infertility. On the weekends, he enjoys outings in his native New York City, manning his barbeque grill, and spending time with his family.


  • Alexander Gorelick
  • Alexander Gorelick

    Clinical Data Programmer

    linkedin

Prior to his work at Celmatix, Alex was an analyst for the opinion polling and market research company, YouGov, where he developed technologies to automate the processing and delivery of survey data and products to clients. He received a BS in Physics at McGill University, where he researched cardiac arrhythmias in post-infarct patients as a way to predict risk of sudden cardiac death. In his spare time, he enjoys playing folk guitar, running, and writing computer programs to analyze social media and open source data.


  • Karen Hunter, PhD
  • Karen Hunter, PhD

    Manager of Clinical Operations

    linkedin

Prior to her work at Celmatix, Karen was a senior analyst at the Dedham Group. She received her undergraduate degrees in Chemical-Biological Engineering and Biology from MIT and a PhD in Cancer Biology from Gerstner Sloan-Kettering Graduate School of Biomedical Sciences.


  • Tina Hu-Seliger, PhD
  • Tina Hu-Seliger, PhD

    Senior Bioinformatics Scientist

    linkedin

Prior to her work at Celmatix, Tina was a postdoctoral researcher at Princeton University where she examined the evolutionary forces impacting lineage-specific patterns in the fruit fly Drosophila. She holds a BS in General Biology and a BA in Mathematics-Computer Science from the University of California, San Diego. Dr. Hu earned both her PhD in Computational Biology and Bioinformatics and her MS in Computational Molecular Biology from the University of Southern California. For fun, she enjoys golfing, skiing, and playing squash.


  • Hrishikesh Karvir, PhD
  • Hrishikesh Karvir, PhD

    Manager of Data Analytics

    linkedin

Prior to his work at Celmatix, Hrishikesh worked as a machine learning scientist at Aureon Biosciences, a diagnostics company developing novel prognostic models and imaging-based biomarkers for prostate cancer. He received an MSc in Biomedical Engineering and a PhD in Engineering from Wright State University, where his doctoral research involved predictive analytics in imaging applications. In his spare time, he enjoys playing basketball, ping-pong and hiking.


  • Emily Lockhart, DMa
  • Emily Lockhart, DMa

    Executive Assistant

    linkedin

Prior to her work at Celmatix, Emily was a classical musician, performing in regional opera houses around the US. In her graduate work, she studied the positive effects of operatic outreach programs on adolescent development. Emily received her undergraduate degree from the University of Oklahoma, her masters degree from the University of Louisville, and a DMA from The University of Texas at Austin. On the weekend, she can be found jogging in central park, singing loudly in public, and baking gluten-free treats in her tiny New York City kitchen.


  • Emlyn Parfitt, PhD
  • Emlyn Parfitt, PhD

    Research Scientist

    linkedin

Prior to his work at Celmatix, Emlyn was a postdoctoral research scientist at Columbia University, where his research focused on defining the gene networks underlying embryonic development and stem cell biology. He received his undergraduate degree in Veterinary Science from the University of Liverpool and a PhD in Embryology from the University of Cambridge. In his spare time, Emlyn likes running and singing, though not at the same time. He also has a pretty serious Netflix addiction, for which is he is seeking help.


Prior to his work at Celmatix, Adam worked as a web developer for the American Society of Engineering Education where he wrote software to administer applications for government educational fellowships. Previously, he worked at The New York Times where he developed a framework for content delivery to mobile applications. He earned a BA in Computer Science from Columbia University and a BA in Philosophy from the Jewish Theological Seminary. In his spare time, he enjoys knitting, photography, and taking his dog to the park.


  • Jennifer Winick, Esq.
  • Jennifer Winick, Esq.

    General Counsel

    linkedin

Prior to her work at Celmatix, Jennifer was a Project Manager at the Garden City Group handling SEC and Class Action Settlements, and was a Patent Litigation Associate at the law firm Fish & Richardson, P.C. She received her undergraduate degree in Computer Science Engineering from University of Pennsylvania, and her Juris Doctor from Brooklyn Law School. On the weekends she likes to run, bike, and spend time with her family.

 

our advisors —corporate

  • Christina Carlisle Jones
  • Christina Carlisle Jones

    Founder & Chief Executive Officer, Extend Fertility, Inc.

    linkedin

Ms. Jones co-founded Trilogy Software and has served as President and Founder of pcOrder. Ms. Jones is an Aspen Institute Henry Crown Fellow and served on the Board of Directors of Fertile Hope, before it was acquired by the Lance Armstrong Foundation. She received a BA in Economics from Stanford University and an MBA from Harvard Business School.


  • Cory Ondrejka
  • Cory Ondrejka

    Vice President of Mobile, Facebook

    linkedin

Mr. Ondrejka’s experience spans several fields from defense contracting to video game development. He co-founded Walletin, which was acquired by Facebook, and Linden Lab, the creator of Second Life. He served as Executive Vice President for Global Digital Marketing at EMI Music and was a visiting professor at the Annenberg School for Communication at the University of Southern California.


  • Greg Yap
  • Greg Yap

    Chief Executive Officer of Biodesy

    linkedin

Mr. Yap is an entrepreneurial leader and general manager with experience building rapidly growing companies in dynamic markets. He was most recently the first healthcare Entrepreneur in Residence at GE. Previously, Mr. Yap also held senior operating and general management roles at Ventana Medical Systems, CELLective Dx, and Affymetrix. Mr. Yap previously worked in venture capital with Bay City Capital and in management consulting with McKinsey & Company. He is a member of the board of directors of Outward Bound California and the national Outward Bound Services Group. Mr. Yap received his MBA from Stanford University and his AB in molecular biology, summa cum laude, from Princeton University.


 

our advisors — scientific

  • Gurinder Singh “Mickey” Atwal, PhD
  • Gurinder Singh “Mickey” Atwal, PhD

    Assistant Professor, Cold Spring Harbor Laboratory

    linkedin

Dr. Atwal is an Assistant Professor at Cold Spring Harbor Laboratory, and an adjunct faculty member of Stony Brook University. After a few years in medical school at the University of Cambridge, when biology was still largely a qualitative science, he opted to break his family’s heart by pursuing a PhD in theoretical physics. As the biological sciences emerges into the quantitative arena, Dr. Atwal finds himself going back almost full-circle, developing and deploying mathematical and computational tools to address quantitative principles governing the behavior of complex biological systems, ranging from biomolecular networks to the evolution of the species Homo sapiens. Fueled by large-scale genotyping technologies, he has recently focused on population genetics with a view to understanding the evolutionary forces at play on the genome and to underpin the genetics of some human diseases, including cancer, infertility and neuropsychiatric disorders.


  • Amber R. Cooper, MD, MSCI
  • Amber R. Cooper, MD, MSCI

    Assistant Professor at Washington University in St. Louis, Missouri

    linkedin

Dr. Cooper is an Assistant Professor at Washington University in St. Louis, Missouri and is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. After graduating first in her medical school class, she went on to complete her residency, fellowship and an additional Master of Science in Clinical Investigation at Washington University and then remained on faculty there. Dr. Cooper has received several awards throughout her training and as a physician-scientist in teaching, clinical care, surgical skills and research. She has ongoing research studies and clinical expertise in the areas of primary ovarian insufficiency (POI/POF), diminished ovarian reserve, genetic and environmental etiologies of ovarian dysfunction, ovarian reserve screens, fertility preservation and the reproductive health of patients with autoimmune disease. She also has clinical interests in the areas of general infertility, in vitro fertilization, preimplantation genetic diagnoses, recurrent pregnancy loss and reproductive surgery.


  • Alan Copperman, MD
  • Alan Copperman, MD

    Director of Infertility & Vice Chairman of Obstetrics and Gynecology, Mount Sinai Medical Center; Co-Founder & Co-Director, RMA of New York

    linkedin

Dr. Copperman is a widely respected Reproductive Endocrinologist. He has published award-winning papers on egg freezing, infertility and IVF. Dr. Copperman has received awards from patient advocacy groups including The American Fertility Association and Resolve. He currently serves on the Fertility Advisory Committee to LIVESTRONG.


  • Roger Gosden, PhD, DSc
  • Roger Gosden, PhD, DSc

    Professor and Director of Research in Reproductive Biology, Weill Medical College of Cornell University, New York, NY (retired)

    linkedin

Dr. Gosden received his research training in Cambridge under the physiologist Robert Edwards who, with the gynecologist Patrick Steptoe, achieved the world’s first successful in vitro fertilization (IVF) pregnancy. Dr. Gosden has remained an active member of the global reproductive biology community through publications and conference lectures.


  • James Hicks, PhD
  • James Hicks, PhD

    Research Professor & Director of Women's Cancer Genomics Initiative, Cold Spring Harbor Laboratory

    linkedin

Dr. Hicks is a leading expert on the role of chromosomal deletions and duplications in cancer and autism. His current research involves applying genome-wide microarray strategies to identify diagnostic and prognostic markers in autism spectrum disorders as well as breast, ovarian and cervical cancer.


  • Richard G. Rawlins, Ph.D, HCLD, ELD (ABB)
  • Richard G. Rawlins, Ph.D, HCLD, ELD (ABB)

    Laboratory Director, Reproductive Medicine Institute, Oak Brook, Illinois; Professor, Rush University Department OBGYN & Department Anatomy and Cell Biology

    linkedin

Dr. Rawlins received his Ph.D. in zoology from Michigan State University in 1984, specializing in the reproductive physiology and preimplantation embryology of nonhuman primates. He joined Rush University Medical Center in Chicago the same year and began development of the Center’s In Vitro Fertilization Program. He also built out and directed the mainland clinics service the metropolitan and greater metropolitan areas of Chicago, downstate Illinois, southern Wisconsin, southern Michigan and all of Indiana. In conjunction with clinical responsibilities, Dr. Rawlins is an active academic. He lectures on reproductive anatomy and histology to medical students, has participated in the Division of Cell Biology in the Rush Graduate College, trained clinical fellows in the ABOG approved clinical Fellowship Program for Reproductive Endocrinology and Infertility at Rush and lectured to the residents on reproductive endocrinology and statistics. Dr. Rawlins has also trained 68 clinicians and biologists in IVF/ART and he has established more than 15 IVF/ART programs globally.


  • Georgia Witkin, PhD
  • Georgia Witkin, PhD

    Assistant Professor of Psychiatry and Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences at the Mount Sinai School of Medicine; Director of Psychological Services for Reproductive Medical Associates of New York

    linkedin

One of the nation’s foremost experts on the psychological issues surrounding ovum donation and fertility treatment, Dr. Witkin is the Director of Psychological Services for Reproductive Medical Associates of New York and serves as Assistant Professor of Psychiatry; Director of the Stress Program; and Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences at the Mount Sinai School of Medicine in New York City. Dr. Witkin serves on several boards including The Women’s Advisory Board of Harvard University’s Kennedy School of Government and has been honored by many national organizations including Resolve, The American Infertility Association, and The American Fertility Association. Dr. Witkin is a bestselling author and television personality who contributes regularly on The FOX News Channel and has appeared on more than 100 shows including 20/20, The Oprah Show, The Today Show, Good Morning America, CBS Evening News, and CNN.

 

our partners

  • RMA of New York
  • RMA of New York

It’s what you want most: to raise and love your own healthy child. At Reproductive Medicine Associates of New York, our mission is to offer patients the most up to date, appropriate infertility treatment available in a caring, compassionate manner. We want your experience with us to be as stress-free and successful as possible.

Our medical facility in Midtown Manhattan, both modern and spacious, is open seven days a week so each patient can be closely monitored. We house our medical suites, in vitro fertilization (IVF) surgical procedures rooms and embryology laboratories all under one roof, enabling us to provide you with continuous, convenient care. In addition, we have satellite offices in Westchester and on Long Island to provide patients closer access to RMA of New York’s services.


  • RMA of Texas
  • RMA of Texas

The Reproductive Medicine Associates of Texas is the premier Texas fertility center. At RMA of Texas, the mission of our team of experienced professionals is to individualize your care to the most appropriate treatment, using the most advanced and safest technologies available.

We want to know you as a person with your own medical, emotional and financial needs while considering your ethical and social values.

Our aim is to make you feel safe and pampered in our stress-free, spa-like Texas fertility clinic while offering cost-effective treatment options. Our main goal is to successfully guide your transformation: Today you, tomorrow a family™.


  • RMA of Philadelphia
  • RMA of Philadelphia

The team at Reproductive Medicine Associates of Philadelphia, formerly Northern Fertility & Reproductive Associates, has helped thousands of women and men in the Delaware Valley achieve their dream of parenthood. We are proud to be a trusted resource for so many hopeful parents – and especially proud of the many families we have helped create.


  • RMA of Michigan
  • RMA of Michigan

RMA of Michigan physicians, Drs. Brad Miller and Lynda Wolf combined have over 30 years of experience in the field of infertility and reproductive endocrinology. Both are board certified in reproductive endocrinology and infertility, each having directed their own IVF program prior to joining RMA of Michigan. With a team of experienced physicians, nurses and embryologists, we strive to provide state of the art care in a convenient, caring and compassionate fashion and to produce the highest pregnancy rates possible.

RMA of Michigan understands the physical and emotional challenge for our patients going through treatment.We have holistic therapy services available for patients, which includes therapeutic massage, Reiki and acupuncture. These services offer a supportive atmosphere to make treatment easier and more comfortable for you. Our goal is to make this experience as positive as possible with a focus on the health of both mind and body


Interested in becoming a Celmatix Partner?

learn more by contacting us


 

our advisors — corporate

  • Christina Carlisle Jones
  • Christina Carlisle Jones

    Founder & Chief Executive Officer, Extend Fertility, Inc.

    linkedin

Ms. Jones co-founded Trilogy Software and has served as President and Founder of pcOrder. Ms. Jones is an Aspen Institute Henry Crown Fellow and served on the Board of Directors of Fertile Hope, before it was acquired by the Lance Armstrong Foundation. She received a BA in Economics from Stanford University and an MBA from Harvard Business School.


  • Cory Ondrejka
  • Cory Ondrejka

    Vice President of Mobile, Facebook

    linkedin

Mr. Ondrejka’s experience spans several fields from defense contracting to video game development. He co-founded Walletin, which was acquired by Facebook, and Linden Lab, the creator of Second Life. He served as Executive Vice President for Global Digital Marketing at EMI Music and was a visiting professor at the Annenberg School for Communication at the University of Southern California.


  • Greg Yap
  • Greg Yap

    Chief Executive Officer, Biodesy

    linkedin

Mr. Yap is an entrepreneurial leader and general manager with experience building rapidly growing companies in dynamic markets. He was most recently the first healthcare Entrepreneur in Residence at GE. Previously, Mr. Yap also held senior operating and general management roles at Ventana Medical Systems, CELLective Dx, and Affymetrix. Mr. Yap previously worked in venture capital with Bay City Capital and in management consulting with McKinsey & Company. He is a member of the board of directors of Outward Bound California and the national Outward Bound Services Group. Mr. Yap received his MBA from Stanford University and his AB in molecular biology, summa cum laude, from Princeton University.


 

our advisors — scientific

  • Gurinder Singh “Mickey” Atwal, PhD
  • Gurinder Singh “Mickey” Atwal, PhD

    Assistant Professor, Cold Spring Harbor Laboratory

    linkedin

Dr. Atwal is an Assistant Professor at Cold Spring Harbor Laboratory, and an adjunct faculty member of Stony Brook University. After a few years in medical school at the University of Cambridge, when biology was still largely a qualitative science, he opted to break his family’s heart by pursuing a PhD in theoretical physics. As the biological sciences emerges into the quantitative arena, Dr. Atwal finds himself going back almost full-circle, developing and deploying mathematical and computational tools to address quantitative principles governing the behavior of complex biological systems, ranging from biomolecular networks to the evolution of the species Homo sapiens. Fueled by large-scale genotyping technologies, he has recently focused on population genetics with a view to understanding the evolutionary forces at play on the genome and to underpin the genetics of some human diseases, including cancer, infertility and neuropsychiatric disorders.


  • Amber R. Cooper, MD, MSCI
  • Amber R. Cooper, MD, MSCI

    Assistant Professor at Washington University in St. Louis, Missouri

    linkedin

Dr. Cooper is an Assistant Professor at Washington University in St. Louis, Missouri and is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. After graduating first in her medical school class, she went on to complete her residency, fellowship and an additional Master of Science in Clinical Investigation at Washington University and then remained on faculty there. Dr. Cooper has received several awards throughout her training and as a physician-scientist in teaching, clinical care, surgical skills and research. She has ongoing research studies and clinical expertise in the areas of primary ovarian insufficiency (POI/POF), diminished ovarian reserve, genetic and environmental etiologies of ovarian dysfunction, ovarian reserve screens, fertility preservation and the reproductive health of patients with autoimmune disease. She also has clinical interests in the areas of general infertility, in vitro fertilization, preimplantation genetic diagnoses, recurrent pregnancy loss and reproductive surgery.


  • Alan Copperman, MD
  • Alan Copperman, MD

    Director of Infertility & Vice Chairman of Obstetrics and Gynecology, Mount Sinai Medical Center; Co-Founder & Co-Director, RMA of New York

    linkedin

Dr. Copperman is a widely respected Reproductive Endocrinologist. He has published award-winning papers on egg freezing, infertility and IVF. Dr. Copperman has received awards from patient advocacy groups including The American Fertility Association and Resolve. He currently serves on the Fertility Advisory Committee to LIVESTRONG.


  • Roger Gosden, PhD, DSc
  • Roger Gosden, PhD, DSc

    Professor and Director of Research in Reproductive Biology, Weill Medical College of Cornell University, New York, NY (retired)

    linkedin

Dr. Gosden received his research training in Cambridge under the physiologist Robert Edwards who, with the gynecologist Patrick Steptoe, achieved the world’s first successful in vitro fertilization (IVF) pregnancy. Dr. Gosden has remained an active member of the global reproductive biology community through publications and conference lectures.


  • James Hicks, PhD
  • James Hicks, PhD

    Research Professor & Director of Women's Cancer Genomics Initiative, Cold Spring Harbor Laboratory

    linkedin

Dr. Hicks is a leading expert on the role of chromosomal deletions and duplications in cancer and autism. His current research involves applying genome-wide microarray strategies to identify diagnostic and prognostic markers in autism spectrum disorders as well as breast, ovarian and cervical cancer.


  • Richard G. Rawlins, Ph.D, HCLD, ELD (ABB)
  • Richard G. Rawlins, Ph.D, HCLD, ELD (ABB)

    Laboratory Director, Reproductive Medicine Institute, Oak Brook, Illinois; Professor, Rush University Department OBGYN & Department Anatomy and Cell Biology

    linkedin

Dr. Rawlins received his Ph.D. in zoology from Michigan State University in 1984, specializing in the reproductive physiology and preimplantation embryology of nonhuman primates. He joined Rush University Medical Center in Chicago the same year and began development of the Center’s In Vitro Fertilization Program. He also built out and directed the mainland clinics service the metropolitan and greater metropolitan areas of Chicago, downstate Illinois, southern Wisconsin, southern Michigan and all of Indiana. In conjunction with clinical responsibilities, Dr. Rawlins is an active academic. He lectures on reproductive anatomy and histology to medical students, has participated in the Division of Cell Biology in the Rush Graduate College, trained clinical fellows in the ABOG approved clinical Fellowship Program for Reproductive Endocrinology and Infertility at Rush and lectured to the residents on reproductive endocrinology and statistics. Dr. Rawlins has also trained 68 clinicians and biologists in IVF/ART and he has established more than 15 IVF/ART programs globally.


  • Georgia Witkin, PhD
  • Georgia Witkin, PhD

    Assistant Professor of Psychiatry and Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences at the Mount Sinai School of Medicine; Director of Psychological Services for Reproductive Medical Associates of New York

    linkedin

One of the nation’s foremost experts on the psychological issues surrounding ovum donation and fertility treatment, Dr. Witkin is the Director of Psychological Services for Reproductive Medical Associates of New York and serves as Assistant Professor of Psychiatry; Director of the Stress Program; and Assistant Professor of Obstetrics, Gynecology and Reproductive Sciences at the Mount Sinai School of Medicine in New York City. Dr. Witkin serves on several boards including The Women’s Advisory Board of Harvard University’s Kennedy School of Government and has been honored by many national organizations including Resolve, The American Infertility Association, and The American Fertility Association. Dr. Witkin is a bestselling author and television personality who contributes regularly on The FOX News Channel and has appeared on more than 100 shows including 20/20, The Oprah Show, The Today Show, Good Morning America, CBS Evening News, and CNN.


  • Laura Towart Bandak, MSc
  • Laura Towart Bandak, MSc

    Founder and Chairman

    linkedin

Laura Towart Bandak holds an MSc degree in Neuroscience from Cornell University (Weill Medical College/Sloan Kettering Institute, NYC). She performed her thesis work on the molecular pharmacology of the mu opioid receptor and is published in the field of gonadal hormones. In addition, Ms. Bandak has had extensive exposure to the biotechnology sector as an independent consultant. Ms. Bandak graduated cum laude from The George Washington University, Washington DC, with a BA in English Honors and a BS in Biology.


  • Piraye Yurttas Beim, PhD
  • Piraye Yurttas Beim, PhD

    Founder and Chief Executive Officer

    linkedin

Regarded as an expert in female infertility, Dr. Beim’s embryology research at Cambridge (UK) and doctoral work at Cornell (Weill) on the molecular genetics of mammalian infertility took a very personal turn when she began to notice many of the successful and career-minded women in her network begin to voice strong concerns about their biological clocks. That is when it dawned on her: What if women could understand their own fertility based on data and biology rather than age alone? How would that change how women made life-defining decisions? In that moment, Celmatix was born. Dr. Beim has also been widely recognized as an emerging business leader. She was most recently named a NYC Venture Fellow by the NYCEDC and to Crain’s 40 Under 40. She lives in New York City with her husband and son.


our partners

  • RMA of New York
  • RMA of New York

It’s what you want most: to raise and love your own healthy child. At Reproductive Medicine Associates of New York, our mission is to offer patients the most up to date, appropriate infertility treatment available in a caring, compassionate manner. We want your experience with us to be as stress-free and successful as possible.

Our medical facility in Midtown Manhattan, both modern and spacious, is open seven days a week so each patient can be closely monitored. We house our medical suites, in vitro fertilization (IVF) surgical procedures rooms and embryology laboratories all under one roof, enabling us to provide you with continuous, convenient care. In addition, we have satellite offices in Westchester and on Long Island to provide patients closer access to RMA of New York’s services.


  • RMA of Texas
  • RMA of Texas

The Reproductive Medicine Associates of Texas is the premier Texas fertility center. At RMA of Texas, the mission of our team of experienced professionals is to individualize your care to the most appropriate treatment, using the most advanced and safest technologies available.

We want to know you as a person with your own medical, emotional and financial needs while considering your ethical and social values.

Our aim is to make you feel safe and pampered in our stress-free, spa-like Texas fertility clinic while offering cost-effective treatment options. Our main goal is to successfully guide your transformation: Today you, tomorrow a family™.


  • RMA of Philadelphia
  • RMA of Philadelphia

The team at Reproductive Medicine Associates of Philadelphia, formerly Northern Fertility & Reproductive Associates, has helped thousands of women and men in the Delaware Valley achieve their dream of parenthood. We are proud to be a trusted resource for so many hopeful parents – and especially proud of the many families we have helped create.


  • RMA of Michigan
  • RMA of Michigan

RMA of Michigan physicians, Drs. Brad Miller and Lynda Wolf combined have over 30 years of experience in the field of infertility and reproductive endocrinology. Both are board certified in reproductive endocrinology and infertility, each having directed their own IVF program prior to joining RMA of Michigan. With a team of experienced physicians, nurses and embryologists, we strive to provide state of the art care in a convenient, caring and compassionate fashion and to produce the highest pregnancy rates possible.

RMA of Michigan understands the physical and emotional challenge for our patients going through treatment.We have holistic therapy services available for patients, which includes therapeutic massage, Reiki and acupuncture. These services offer a supportive atmosphere to make treatment easier and more comfortable for you. Our goal is to make this experience as positive as possible with a focus on the health of both mind and body


Interested in becoming a Celmatix Partner?

learn more by contacting us


The Leadership Team


  • Michael Elashoff, PhD
  • Michael Elashoff, PhD

    Vice President of Research & Development

    linkedin

Prior to his work at Celmatix, Mike was the Senior Director of Biostatistics at CardioDx, where he developed the Corus CAD test, the first blood based molecular diagnostic for coronary disease. Previously, he was director of biostatistics at Gene Logic, which at that time had the largest genomic database in the world, and was a reviewer and team leader at the FDA’s Center for Drug Evaluation and Research. He received an undergraduate degree in Statistics from the University of California at Berkeley and a PhD in Biostatistics from the Harvard University School of Health. Besides research/science, he plays pool and soccer.


  • Angie Lee
  • Angie Lee

    Vice President of Product & Marketing

    linkedin

Prior to joining Celmatix, Angie held senior leadership roles overseeing marketing and product at General Assembly, IDEO, HarperCollins Publishers and News Corporation. She earned her BA from the Business Honors Program at The University of Texas at Austin and an MBA with concentrations in Strategy and Marketing from New York University’s Stern School of Business. On the weekends, you can find her picnicking in Prospect Park, Brooklyn with her husband and two kids.


  • James Leslie
  • James Leslie

    Chief Financial Officer

    linkedin

Prior to his work at Celmatix, he was CFO of TitleVest, a tech-enabled company operating in the real estate space where he oversaw all financial functions while also providing strategic and operational direction during a period where the company tripled in size and expanded across the US. Formerly, James was as an investment banker with The Blackstone Group, a global investment and advisory firm, where he advised institutional clients on numerous multi-billion dollar transactions, offering guidance on financial planning and budgeting, cash flow forecasting, strategic and operational planning and capital structure considerations. He earned an undergraduate degree from from Vassar College and an MBA from Columbia Business School. In his spare time, James races J/24 sailboats and runs the occasional 10k.


Steve serves as the Managing Director of Topspin Partners. Steve came to Topspin from Honeywell, Intl., where he most recently served as CIO of its $2 billion Security Group. He had been with Honeywell (and the Ademco division of Pittway Corp., before its acquisition by Honeywell in 2000) for over 21 years as CTO of the security business, as well as founder and president of its wireless communications services business. Steve also serves on the Board of the Long Island Angel Network. Steve received a BS in Economics from the Wharton School of the University of Pennsylvania and a BS in Electrical Engineering, also from Penn. He received his JD from Georgetown University Law Center and is both a member of the Bar of the State of New York, and a registered Patent Attorney.


The Celmatix Team


  • Benjamin Burnett
  • Benjamin Burnett

    Bioinformatics Associate

    linkedin

Prior to joining the Celmatix team, Ben was a research associate at the Itsik Pe’er Lab of Computational Genetics, where he developed pipelines to analyze epistatic interactions in diseased individuals across the human genome. In addition, he spearheaded the development of novel fixatives and delivery methods for the fragrance company Nomaterra. Ben graduated with honors from Columbia University with a BS in Biochemistry and Mathematics. In his spare time, he loves travel and playing music.


  • Rebecca Chodroff, PhD
  • Rebecca Chodroff, PhD

    Product Manager

    linkedin

Prior to her work at Celmatix, Rebecca was a recipient of an NIH-Oxford Biomedical Research Scholarship which allowed her to split her graduate studies between Oxford University and the National Human Genome Research Institute. She received her undergraduate degree in Neuroscience and Anthropology from the University of Pennsylvania where she graduated summa cum laude, and a PhD in Genetics from Oxford University where her thesis focused on elucidating the roles of non-protein-coding RNAs in mammalian brain development. When not at work, she can be found jogging through Prospect Park, drinking very strong coffee, or looking for new places to sail.


Prior to his work at Celmatix, Nick was a web developer at the Strategic Resource Group in New York, where he designed and developed web products for retail and consumer packaged goods companies. He received his undergraduate degree in Ecology and Evolutionary Biology from Princeton University in 2011, where he used geospatial analysis to assess the potential impact of climate change on the stream ecosystems of Montana. In his spare time he likes to long bicycle rides on the beach and starting new hobbies.


  • Charlotte Frank Sage, PhD
  • Charlotte Frank Sage, PhD

    Manager of Clinical Affairs

    linkedin

Prior to her work at Celmatix, Charlotte was the Vice President of Clinical Affairs and Operations at Extend Fertility, a pioneering company in the field of female fertility preservation. She received her undergraduate degree in Molecular Biology and Biochemistry from Wesleyan University where she graduated first in her class. She holds a PhD in Microbiology from Yale University, where she studied the interactions of the yeast Candida albicans with human intestinal epithelial cells. She also enjoys teaching the next generation of scientists as part of the Overnight Program at the Museum of Science, Boston.


  • Sam Globus, PhD
  • Sam Globus, PhD

    Manager of Scientific Operations

    linkedin

Prior to his work at Celmatix, Sam was an Associate Consultant at Bionest Partners. Sam received his undergraduate degree from Wesleyan University, an MA in Biotechnology from Columbia, and an MSc in the History of Science and Technology from Oxford. He completed a PhD in Molecular Biology and Biochemisty from Weill Cornell University Medical College where his research, performed at the Memorial Sloan-Kettering Cancer Center, focused on the basic molecular processes that can lead to infertility. On the weekends, he enjoys outings in his native New York City, manning his barbeque grill, and spending time with his family.


  • Alexander Gorelick
  • Alexander Gorelick

    Clinical Data Programmer

    linkedin

Prior to his work at Celmatix, Alex was an analyst for the opinion polling and market research company, YouGov, where he developed technologies to automate the processing and delivery of survey data and products to clients. He received a BS in Physics at McGill University, where he researched cardiac arrhythmias in post-infarct patients as a way to predict risk of sudden cardiac death. In his spare time, he enjoys playing folk guitar, running, and writing computer programs to analyze social media and open source data.


  • Karen Hunter, PhD
  • Karen Hunter, PhD

    Manager of Clinical Operations

    linkedin

Prior to her work at Celmatix, Karen was a senior analyst at the Dedham Group. She received her undergraduate degrees in Chemical-Biological Engineering and Biology from MIT and a PhD in Cancer Biology from Gerstner Sloan-Kettering Graduate School of Biomedical Sciences.


  • Tina Hu-Seliger, PhD
  • Tina Hu-Seliger, PhD

    Senior Bioinformatics Scientist

    linkedin

Prior to her work at Celmatix, Tina was a postdoctoral researcher at Princeton University where she examined the evolutionary forces impacting lineage-specific patterns in the fruit fly Drosophila. She holds a BS in General Biology and a BA in Mathematics-Computer Science from the University of California, San Diego. Dr. Hu earned both her PhD in Computational Biology and Bioinformatics and her MS in Computational Molecular Biology from the University of Southern California. For fun, she enjoys golfing, skiing, and playing squash.


  • Hrishikesh Karvir, PhD
  • Hrishikesh Karvir, PhD

    Manager of Data Analytics

    linkedin

Prior to his work at Celmatix, Hrishikesh worked as a machine learning scientist at Aureon Biosciences, a diagnostics company developing novel prognostic models and imaging-based biomarkers for prostate cancer. He received an MSc in Biomedical Engineering and a PhD in Engineering from Wright State University, where his doctoral research involved predictive analytics in imaging applications. In his spare time, he enjoys playing basketball, ping-pong and hiking.


  • Emily Sáenz, DMA
  • Emily Sáenz, DMA

    Executive Assistant

    linkedin

Prior to her work at Celmatix, Emily was a classical musician, performing in regional opera houses around the US. In her graduate work, she studied the positive effects of operatic outreach programs on adolescent development. Emily received her undergraduate degree from the University of Oklahoma, her masters degree from the University of Louisville, and a DMA from The University of Texas at Austin. On the weekend, she can be found jogging in central park, singing loudly in public, and baking gluten-free treats with her husband in their tiny New York City kitchen.


  • Emlyn Parfitt, PhD
  • Emlyn Parfitt, PhD

    Research Scientist

    linkedin

Prior to his work at Celmatix, Emlyn was a postdoctoral research scientist at Columbia University, where his research focused on defining the gene networks underlying embryonic development and stem cell biology. He received his undergraduate degree in Veterinary Science from the University of Liverpool and a PhD in Embryology from the University of Cambridge. In his spare time, Emlyn likes running and singing, though not at the same time. He also has a pretty serious Netflix addiction, for which is he is seeking help.


Prior to his work at Celmatix, Adam worked as a web developer for the American Society of Engineering Education where he wrote software to administer applications for government educational fellowships. Previously, he worked at The New York Times where he developed a framework for content delivery to mobile applications. He earned a BA in Computer Science from Columbia University and a BA in Philosophy from the Jewish Theological Seminary. In his spare time, he enjoys knitting, photography, and taking his dog to the park.


  • Jennifer Winick, Esq.
  • Jennifer Winick, Esq.

    General Counsel

    linkedin

Prior to her work at Celmatix, Jennifer was a Project Manager at the Garden City Group handling SEC and Class Action Settlements, and was a Patent Litigation Associate at the law firm Fish & Richardson, P.C. She received her undergraduate degree in Computer Science Engineering from University of Pennsylvania, and her Juris Doctor from Brooklyn Law School. On the weekends she likes to run, bike, and spend time with her family.